CytoDyn Inc. (OTC: CYDY) CEO Interview with Nader Pourhassan, Ph.D, discussing CytoDyn’s PRO140 monoclonal antibody therapy for HIV and cancer. The company is at a […]
Trendlines Group, Ltd. (OTC: TRNLY) (Singapore: 42T), interview with co-CEO/Chairman Steve Rhodes, discussing the company’s investment strategy in early-stage medical and agricultural innovation companies in Israel and Singapore. Since […]
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) interview with CEO, Chaim Lebovits, discussing the company’s advancements in developing stem cell therapies to treat neurodegenerative diseases. The company’s pipeline includes a lead indication for ALS- Amyotrophic Lateral […]
Companies Anticipate Another Precedential Ruling from the Federal Circuit Three Judge Panel Based on One Over-Arching Argument LOS ANGELES, CA / ACCESSWIRE / December 19, 2018 / Decision Diagnostics Corp. (otc pink:DECN) Decision Diagnostics Corp. […]
Pluristem Therapeutics, Inc. (NASDAQ: PSTI), interview with co-CEO Yaky Yanay. Yaky explains Pluristem’s regenerative medicine technologies, which use placenta-derived cell products, and address multi-billion health markets. Pluristem has 3 […]
InnerScope adds Newegg.com and Wish.com websites and continues to expand its eCommerce Direct-to-Consumer sales platforms for its FDA-Registered Hearing Aids and its Personal Sound Amplifier Products to being sold on the world’s largest digital shopping malls, including Walmart.com and Amazon.com ROSEVILLE, Calif., […]
Company Also Readies Imminent Appeal in The Johnson & Johnson Patent Infringement Matter With The U.S. Court Of Appeals for The Federal Circuit LOS ANGELES, CA – December 17, 2018 Decision Diagnostics Corp. (OTC: DECN) […]
IP AND PRODUCTS STRATEGY IS PUT IN PLACE TO INCREASE REVENUES, BUILD THE BRAND AND POSITION THE COMPANY FOR A HANDSOME SETTLEMENT OR M&A TRANSACTION ++ LOS ANGELES, CA – December 11, 2018 – Decision Diagnostics […]
Global Cannabis Applications Corp. (CSE: APP) (OTC: FUAPF) Interview with CEO, Brad More discussing the companies data technologies for helping standardize and improve medicinal cannabis results for […]
DECN Receives Completed Clinical Trials Report from its IRB and Anticipates Filing U.S. FDA 510k Application for its Genchoice! Product on December 21, 2018 December 04, 2018 — DECN to Launch Genchoice! Product in Select […]
InnerScope reports profitable quarter and progress in its online Hearing Aids Sales through Walmart.com and other Direct-to-Consumer sales platforms ROSEVILLE, Calif., Nov 26, 2018 –InnerScope Hearing Technologies Inc. (OTCQB:INND), a manufacturer and distributor of hearing […]
Medibio (ASX: MEB) (OTC: MDBIF) CEO Interview with David Kaysen. Mr. Kaysen recently came on board as the new CEO, in this interview he discusses Medibio’s mental health […]
Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.
TORONTO, Nov. 13, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or the “Company“) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that the license of its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”) under the […]
FSD Pharma, Inc (CSE: HUGE) (OTC: FSDDF) CEO Interview with Dr. Raza Bokhari. FSD Pharma is building the worlds largest licensed indoor cannabis growing facility […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
